Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 11/20 | 0.37 |
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26596989 | 0.86 | ALOX5AP (0.40) | ALOX5APMAPTCDC7CDK2PRKCZ | |
| SCHEMBL22793033 | 0.81 | ALOX5AP (0.38) | ALOX5APMAPTAOC3KCNH2CYP19A1 | |
| SCHEMBL22792805 | 0.79 | MAPT (0.37) | ALOX5APMAPTAOC3KCNH2CYP19A1 | |
| SCHEMBL19233685 | 0.77 | MAPT (0.46) | MAPTCDC7CDK2KCNH2CYP19A1 | |
| SCHEMBL26596972 | 0.74 | KMT2A (0.36) | ALOX5APMAPTKCNH2KDM4E | |
| SCHEMBL26618989 | 0.71 | DHFR (0.38) | ALOX5APCDC7CDK2 | |
| SCHEMBL22792465 | 0.67 | MAPT (0.44) | MAPTCDC7CDK2AOC3KCNH2 | |
| SCHEMBL26597001 | 0.67 | ATM (0.43) | ALOX5APMAPTCDC7CDK2KDM4E | |
| SCHEMBL16083813 | 0.66 | AOC3 (0.65) | AOC3KCNH2CYP19A1 | |
| SCHEMBL12775610 | 0.66 | CYP17A1 (0.41) | MAPTCDC7CDK2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | ALOX5AP 792/4885MAPT 4199/4885CDC7 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.